Menopause
    
    
  
  Conference Coverage
New agent builds bone bigger, faster
Key clinical point: A novel anabolic agent being developed for the treatment of postmenopausal osteoporosis increased BMD faster and to a greater...
Conference Coverage
Systemwide disparities seen in diagnosis, care of women with heart disease
Conference Coverage
Denosumab's benefits persist through 8 years
Key clinical point: An ongoing major study provides reassurance regarding the long-term safety and effectiveness of denosumab for postmenopausal...
News
Women’s Health Initiative study netted $37 billion in savings
Major Finding: The WHI resulted in $35.2 billion in direct medical expenditure savings, most of which came from fewer combined HT users and...
News
Yearly monitoring does not predict fractures after bisphosphonate cessation
Conference Coverage
Topical lidocaine reduces menopausal dyspareunia
Key clinical point: Consider lidocaine as an option for women with severe menopausal dyspareunia for whom estrogen therapy is not recommended....
News
Menopause doesn’t drive severe asthma
Major finding: The odds ratio for severe asthma was 5.62 for menopausal vs. premenopausal women in unadjusted analysis, but 1.46 after adjustment....
Conference Coverage
It’s time to put to rest the calcium supplement controversy
Guidelines
New stroke guidelines focus on women’s risks
News
Romosozumab boosts bone density while cutting resorption
Major finding: Women who received the highest monthly dose of romosozumab showed a mean increase in BMD of 11.3% at the lumbar spine, 4.1% at the...
 
                             